Suppr超能文献

相似文献

1
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.
Cancer Immunol Immunother. 2018 Jul;67(7):1147-1157. doi: 10.1007/s00262-018-2171-7. Epub 2018 May 24.
2
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.
Cancer Immunol Immunother. 2017 Sep;66(9):1199-1204. doi: 10.1007/s00262-017-2015-x. Epub 2017 May 13.
3
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
Cancer Immunol Immunother. 2018 May;67(5):805-814. doi: 10.1007/s00262-018-2138-8. Epub 2018 Feb 27.
5
Immunohistochemical Analysis of Foxp3, CD4, CD8 Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma.
Pathol Oncol Res. 2018 Jul;24(3):497-505. doi: 10.1007/s12253-017-0270-y. Epub 2017 Jul 1.
6
PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases.
Am J Dermatopathol. 2018 Sep;40(9):647-654. doi: 10.1097/DAD.0000000000001164.
8
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.
Cancer Immunol Immunother. 2019 Jun;68(6):951-960. doi: 10.1007/s00262-019-02334-8. Epub 2019 Apr 5.
10

引用本文的文献

1
Generalised eruptive keratoacanthomas of Grzybowski.
BMJ Case Rep. 2024 Mar 21;17(3):e260007. doi: 10.1136/bcr-2024-260007.
5
6
Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.
Sci Rep. 2021 May 24;11(1):10731. doi: 10.1038/s41598-021-90200-y.
7
Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Int J Mol Sci. 2020 Apr 22;21(8):2956. doi: 10.3390/ijms21082956.
9
Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.
Clin Exp Immunol. 2019 Sep;197(3):341-351. doi: 10.1111/cei.13309. Epub 2019 May 30.

本文引用的文献

1
PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast.
Mod Pathol. 2017 Nov;30(11):1551-1560. doi: 10.1038/modpathol.2017.79. Epub 2017 Jul 21.
3
Immunohistochemical Analysis of Foxp3, CD4, CD8 Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma.
Pathol Oncol Res. 2018 Jul;24(3):497-505. doi: 10.1007/s12253-017-0270-y. Epub 2017 Jul 1.
4
PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma.
Pathology. 2017 Aug;49(5):499-505. doi: 10.1016/j.pathol.2017.04.004. Epub 2017 Jun 27.
5
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.
J Clin Invest. 2017 Aug 1;127(8):2930-2940. doi: 10.1172/JCI91190. Epub 2017 Jun 26.
6
Immunotherapy in head and neck cancer: aiming at EXTREME precision.
BMC Med. 2017 Jun 2;15(1):110. doi: 10.1186/s12916-017-0879-4.
7
Skin Cancers in Organ Transplant Recipients.
Am J Transplant. 2017 Oct;17(10):2509-2530. doi: 10.1111/ajt.14382. Epub 2017 Sep 14.
8
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.
Cancer Immunol Immunother. 2017 Sep;66(9):1199-1204. doi: 10.1007/s00262-017-2015-x. Epub 2017 May 13.
9
Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
PLoS One. 2017 Apr 19;12(4):e0175755. doi: 10.1371/journal.pone.0175755. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验